Q4 2022 Immunoprecise Antibodies Ltd Earnings Call Transcript
Good morning and thank you for joining us. My name is Chantel, and I will be your conference operator today. Welcome to IPA's fourth quarter and fiscal year-end earnings conference call. Also on the call with me today are Jennifer Bath, Chief Executive Officer; Lisa Helbling, Chief Financial Officer; and Brad McConn, Vice President of Finance.
Before we get started, some statements we make today may be considered forward-looking statements for the purpose of applicable United States and Canadian security laws. IPA cautions that these forward-looking statements are subject to risks and uncertainties and may cause actual results to differ materially from those indicated in these forward-looking statements. Additional information about these risks and uncertainties is included in our SEC filing. IPA undertakes no obligations to update the forward-looking statements, except as required by law.
On today's conference call, non-GAAP financial measures will be used to help investors understand IPA's business performance. We refer current and potential investors to the forward-looking information
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |